Quantitative Magnetization Transfer in Monitoring Glioblastoma (GBM) Response to Therapy

Quantitative magnetization transfer (qMT) was used as a biomarker to monitor glioblastoma (GBM) response to chemo-radiation and identify the earliest time-point qMT could differentiate progressors from non-progressors. Nineteen GBM patients were recruited and MRI-scanned before (Day(0)), two weeks (...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehrabian, Hatef, Myrehaug, Sten, Soliman, Hany, Sahgal, Arjun, Stanisz, Greg J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802834/
https://www.ncbi.nlm.nih.gov/pubmed/29410469
http://dx.doi.org/10.1038/s41598-018-20624-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802834/
https://www.ncbi.nlm.nih.gov/pubmed/29410469
http://dx.doi.org/10.1038/s41598-018-20624-6

Ejemplares similares